AVEO must raise cash in 2018 The question is whether they will do it before or after their coming TIVO-3 results are read out. Q3/18 scheduled release of TIVO-3 Renal Cell Carcinoma Progression Free Survival results. Positive TIVO-3 results are a likely sell-the-news event, if they haven't raised cash at that point.